Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Koos A H Zwinderman"'
Autor:
Luuk Wieske, Laura Y. L. Kummer, Koos P. J. van Dam, Eileen W. Stalman, Anneke J. van der Kooi, Joost Raaphorst, Mark Löwenberg, R. Bart Takkenberg, Adriaan G. Volkers, Geert R. A. M. D’Haens, Sander W. Tas, Phyllis I. Spuls, Marcel W. Bekkenk, Annelie H. Musters, Nicoline F. Post, Angela L. Bosma, Marc L. Hilhorst, Yosta Vegting, Frederike J. Bemelman, Joep Killestein, Zoé L. E. van Kempen, Alexandre E. Voskuyl, Bo Broens, Agner Parra Sanchez, Gertjan Wolbink, Laura Boekel, Abraham Rutgers, Karina de Leeuw, Barbara Horváth, Jan J. G. M. Verschuuren, Annabel M. Ruiter, Lotte van Ouwerkerk, Diane van der Woude, Cornelia F. Allaart, Y. K. Onno Teng, Pieter van Paassen, Matthias H. Busch, B. Papay Jallah, Esther Brusse, Pieter A. van Doorn, Adája E. Baars, Dirkjan Hijnen, Corine R. G. Schreurs, W. Ludo van der Pol, H. Stephan Goedee, Maurice Steenhuis, Theo Rispens, Anja ten Brinke, Niels J. M. Verstegen, Koos A. H. Zwinderman, S. Marieke van Ham, Taco W. Kuijpers, Filip Eftimov, on behalf of the T2B! immunity against SARS-CoV-2 study group
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-6 (2022)
Abstract Background Studies have suggested incremental short-term adverse events (AE) after repeated vaccination. In this report, we assessed occurrence and risk factors for short-term AEs following repeated SARS-CoV-2 vaccination in patients with va
Externí odkaz:
https://doaj.org/article/67db8621c3964b7a9443d09b66e09e5f
Autor:
Laura Boekel, Eileen W Stalman, Luuk Wieske, Femke Hooijberg, Koos P J van Dam, Yaëlle R Besten, Laura Y L Kummer, Maurice Steenhuis, Zoé L E van Kempen, Joep Killestein, Adriaan G Volkers, Sander W Tas, Anneke J van der Kooi, Joost Raaphorst, Mark Löwenberg, R Bart Takkenberg, Geert R A M D'Haens, Phyllis I Spuls, Marcel W Bekkenk, Annelie H Musters, Nicoline F Post, Angela L Bosma, Marc L Hilhorst, Yosta Vegting, Frederike J Bemelman, Alexandre E Voskuyl, Bo Broens, Agner Parra Sanchez, Cécile A C M van Els, Jelle de Wit, Abraham Rutgers, Karina de Leeuw, Barbara Horváth, Jan J G M Verschuuren, Annabel M Ruiter, Lotte van Ouwerkerk, Diane van der Woude, Cornelia F Allaart, Y K Onno Teng, Pieter van Paassen, Matthias H Busch, Papay B P Jallah, Esther Brusse, Pieter A van Doorn, Adája E Baars, Dirk Jan Hijnen, Corine R G Schreurs, W Ludo van der Pol, H Stephan Goedee, Erik H Vogelzang, Maureen Leeuw, Sadaf Atiqi, Ronald van Vollenhoven, Martijn Gerritsen, Irene E van der Horst-Bruinsma, Willem F Lems, Mike T Nurmohamed, Maarten Boers, Sofie Keijzer, Jim Keijser, Carolien van de Sandt, Arend Boogaard, Olvi Cristianawati, Anja ten Brinke, Niels J M Verstegen, Koos A H Zwinderman, S Marieke van Ham, Theo Rispens, Taco W Kuijpers, Gertjan Wolbink, Filip Eftimov, Rivka de Jongh, Lisan Kuijper, Mariel Duurland, Ruth Hagen, Jet van den Dijssel, Christine Kreher, Amelie Bos, Viriginia Palomares Cabeza, Veronique Konijn, George Elias, Juan Vallejo, Marrit van Gils, Tom Ashhurst, Sergey Nejentsev, Elham Mirfazeli
Publikováno v:
The Lancet Rheumatology, 4(6), e417-e429. Lancet Publishing Group
The Lancet. Rheumatology, 4, e417-e429
T2B! immunity against SARS-CoV-2 study group 2022, ' Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants : a substudy of two prospective cohort studies ', The Lancet Rheumatology, vol. 4, no. 6, pp. e417-e429 . https://doi.org/10.1016/S2665-9913(22)00102-3
The Lancet Rheumatology, 4(6), E417-E429. ELSEVIER
The Lancet. Rheumatology, 4, 6, pp. e417-e429
The Lancet. Rheumatology, 4(6), e417-e429. Elsevier Ltd
The Lancet Rheumatology, 4(6), e417-e429. Elsevier
The Lancet. Rheumatology, 4, e417-e429
T2B! immunity against SARS-CoV-2 study group 2022, ' Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants : a substudy of two prospective cohort studies ', The Lancet Rheumatology, vol. 4, no. 6, pp. e417-e429 . https://doi.org/10.1016/S2665-9913(22)00102-3
The Lancet Rheumatology, 4(6), E417-E429. ELSEVIER
The Lancet. Rheumatology, 4, 6, pp. e417-e429
The Lancet. Rheumatology, 4(6), e417-e429. Elsevier Ltd
The Lancet Rheumatology, 4(6), e417-e429. Elsevier
Contains fulltext : 251784.pdf (Publisher’s version ) (Closed access) BACKGROUND: Concerns have been raised regarding the risks of SARS-CoV-2 breakthrough infections in vaccinated patients with immune-mediated inflammatory diseases treated with imm
Autor:
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, Eileen W Stalman, Laura Y L Kummer, Zoé L E van Kempen, Joep Killestein, Adriaan G Volkers, Sander W Tas, Laura Boekel, Gerrit J Wolbink, Anneke J van der Kooi, Joost Raaphorst, Mark Löwenberg, R Bart Takkenberg, Geert R A M D'Haens, Phyllis I Spuls, Marcel W Bekkenk, Annelie H Musters, Nicoline F Post, Angela L Bosma, Marc L Hilhorst, Yosta Vegting, Frederike J Bemelman, Alexandre E Voskuyl, Bo Broens, Agner Parra Sanchez, Cécile A C M van Els, Jelle de Wit, Abraham Rutgers, Karina de Leeuw, Barbara Horváth, Jan J G M Verschuuren, Annabel M Ruiter, Lotte van Ouwerkerk, Diane van der Woude, Renée C F Allaart, Y K Onno Teng, Pieter van Paassen, Matthias H Busch, Papay B P Jallah, Esther Brusse, Pieter A van Doorn, Adája E Baars, Dirk Jan Hijnen, Corine R G Schreurs, W Ludo van der Pol, H Stephan Goedee, Sofie Keijzer, Jim B D Keijser, Arend Boogaard, Olvi Cristianawati, Anja ten Brinke, Niels J M Verstegen, Koos A H Zwinderman, S Marieke van Ham, Taco W Kuijpers, Theo Rispens, Filip Eftimov, R. de Jongh, C.E. van de Sandt, L. Kuijper, M. Duurland, R.R. Hagen, J. van den Dijssel, C. Kreher, A. Bos, V. Palomares Cabeza, V.A.L. Konijn, G. Elias, J.G. Vallejo, M.J. van Gils, T.M. Ashhurst, S. Nejentsev, E.S. Mirfazeli
Publikováno v:
The Lancet Rheumatology, 4(5), e338-e350. Elsevier
The Lancet. Rheumatology, 4(5), e338-e350. Elsevier Ltd
The Lancet Rheumatology, 4(5), E338-E350. ELSEVIER
T2B! immunity against SARS-CoV-2 study group 2022, ' Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants : a cohort study ', The Lancet Rheumatology, vol. 4, no. 5, pp. e338-e350 . https://doi.org/10.1016/S2665-9913(22)00034-0
The Lancet Rheumatology, 4(5), e338-e350. Lancet Publishing Group
The Lancet Rheumatology, 4(5), E338-E350. Lancet Publishing Group
The Lancet. Rheumatology, 4(5), e338-e350. Elsevier Ltd
The Lancet Rheumatology, 4(5), E338-E350. ELSEVIER
T2B! immunity against SARS-CoV-2 study group 2022, ' Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants : a cohort study ', The Lancet Rheumatology, vol. 4, no. 5, pp. e338-e350 . https://doi.org/10.1016/S2665-9913(22)00034-0
The Lancet Rheumatology, 4(5), e338-e350. Lancet Publishing Group
The Lancet Rheumatology, 4(5), E338-E350. Lancet Publishing Group
Background: Disease-specific studies have reported impaired humoral responses after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated with specific immunosuppressants. Disease-overarching studies, and data on reca
Autor:
Fleur M, van der Valk, Simone L, Verweij, Koos A H, Zwinderman, Aart C, Strang, Yannick, Kaiser, Henk A, Marquering, Aart J, Nederveen, Erik S G, Stroes, Hein J, Verberne, James H F, Rudd
Publikováno v:
Jacc. Cardiovascular Imaging
Objectives This study assessed 5 frequently applied arterial 18fluorodeoxyglucose (18F-FDG) uptake metrics in healthy control subjects, those with risk factors and patients with cardiovascular disease (CVD), to derive uptake thresholds in each subjec
Autor:
Olivier van der Veer, Philip C. De Witt Hamer, Mark ter Laan, Bas Idema, Sytske Boomstra, Michiel Wagemakers, Koos A. H. Zwinderman, Vincent K Y Ho, Clemens M F Dirven, Pierre A. Robe, Hilko Ardon, Fred Kloet, Jan Koopmans, Linda Ackermans, Niels A van der Gaag, Marco J. T. Verstegen, Wimar A. van den Brink, Wim Bouwknegt
Publikováno v:
Neuro-Oncology. 20:vi251-vi252
PURPOSE: To measure between-hospital variation in risk-standardized survival outcome after glioblastoma surgery and to explore the association between survival and hospital characteristics in conjunction with patient-related risk factors. METHODS: Da
Autor:
Koos A. H. Zwinderman, Leonard J. van Boven, Menno R. Germans, Gerrit J. Bouma, Philip C. De Witt Hamer
Publikováno v:
Germans, M R, Verselewel de Witt Hamer, P C, van Boven, L J, Zwinderman, K & Bouma, G J 2010, ' Blood volume measurement with indocyanine green pulse spectrophotometry: dose and site of dye administration ', Acta Neurochirurgica, vol. 152, no. 2, pp. 251-255 . https://doi.org/10.1007/s00701-009-0501-4
Acta Neurochirurgica
Acta Neurochirurgica, 152(2), 251-255. Springer Wien
Acta neurochirurgica, 152(2), 251-5; discussion 255. Springer Wien
Acta neurochirurgica, 152(2), 251-255. Springer Wien
Acta Neurochirurgica
Acta Neurochirurgica, 152(2), 251-255. Springer Wien
Acta neurochirurgica, 152(2), 251-5; discussion 255. Springer Wien
Acta neurochirurgica, 152(2), 251-255. Springer Wien
Background (1) To determine the optimal administration site and dose of indocyanine green (ICG) for blood volume measurement using pulse spectrophotometry, (2) to assess the variation in repeated blood volume measurements for patients after subarachn
Autor:
Nicolet C M Theunissen, Sylvia Veen, Minne Fekkes, Hendrik M Koopman, Koos A H Zwinderman, Emily Brugman, Jan-Maarten Wit
Publikováno v:
Developmental Medicine & Child Neurology. 43:460-465
Autor:
Koos A H Zwinderman, Paul Brinkman, Anna L. Peters, Marije G Gerritsen, Lieuwe D. J. Bos, Alexander P.J. Vlaar
Publikováno v:
Journal of breath research, 11(2):026003. IOP Publishing Ltd.
Systemic inflammatory response syndrome (SIRS) is observed during critical illness in most patients. It is defined by a clinical definition. The composition of volatile organic compounds (VOCs) in exhaled breath may change during SIRS and may thus se
Autor:
Keijzer, Sofie, Oskam, Nienke, Ooijevaar-de Heer, Pleuni, Steenhuis, Maurice, Keijser, Jim B. D., Wieske, Luuk, van Dam, Koos P. J., Stalman, Eileen W., Kummer, Laura Y. L., Boekel, Laura, Kuijpers, Taco W., ten Brinke, Anja, van Ham, S. Marieke, Eftimov, Filip, Tas, Sander W., Wolbink, Gerrit J., Rispens, Theo
Publikováno v:
Frontiers in Immunology; 2024, p1-11, 11p
Autor:
Anna L Peters, Marije G Gerritsen, Paul Brinkman, Koos A H Zwinderman, Alexander P J Vlaar, Lieuwe D Bos
Publikováno v:
Journal of Breath Research; 6/1/2017, Vol. 11 Issue 2, p1-1, 1p